Abstract:BACKGROUND:Vascular growth followed by vessel specification is crucial for the establishment of a hierarchical blood vascular network. We have shown that TIE2 is required for vein development while little is known about its homologue TIE1 (tyrosine kinase with immunoglobulin-like and EGF [epithelial growth factor]-like domains 1) in this process. METHODS:We analyzed functions of TIE1 as well as its synergy with TIE2 in the regulation of vein formation by employing genetic mouse models targeting Tie1, Tek, and Nr2f2, together with in vitro cultured endothelial cells to decipher the underlying mechanism. RESULTS:Cardinal vein growth appeared normal in TIE1-deficient mice, whereas TIE2 deficiency altered the identity of cardinal vein endothelial cells with the aberrant expression of DLL4 (delta-like canonical Notch ligand 4). Interestingly, the growth of cutaneous veins, which was initiated at approximately embryonic day 13.5, was retarded in mice lack of TIE1. TIE1 deficiency disrupted the venous integrity, displaying increased sprouting angiogenesis and vascular bleeding. Abnormal venous sprouts with defective arteriovenous alignment were also observed in the mesenteries of Tie1-deleted mice. Mechanistically, TIE1 deficiency resulted in the decreased expression of venous regulators including TIE2 and COUP-TFII (chicken ovalbumin upstream promoter transcription factor, encoded by Nr2f2, nuclear receptor subfamily 2 group F member 2) while angiogenic regulators were upregulated. The alteration of TIE2 level by TIE1 insufficiency was further confirmed by the siRNA-mediated knockdown of Tie1 in cultured endothelial cells. Interestingly, TIE2 insufficiency also reduced the expression of TIE1. Combining the endothelial deletion of Tie1 with 1 null allele of Tek resulted in a progressive increase of vein-associated angiogenesis leading to the formation of vascular tufts in retinas, whereas the loss of Tie1 alone produced a relatively mild venous defect. Furthermore, the induced deletion of endothelial Nr2f2 decreased both TIE1 and TIE2. CONCLUSIONS:Findings from this study imply that TIE1 and TIE2, together with COUP-TFII, act in a synergistic manner to restrict sprouting angiogenesis during the development of venous system.

VEGF, Notch and TGFβ/BMPs in regulation of sprouting angiogenesis and vascular patterning.

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

Dll4 and Notch signalling couples sprouting angiogenesis and artery formation

BMP9/ALK1/Endoglin Signaling Regulates the Angiogenesis and Vascular Homeostasis

Bone Morphogenetic Proteins in Vascular Homeostasis and Disease

Integrative modeling of sprout formation in angiogenesis: coupling the VEGFA-Notch signaling in a dynamic stalk-tip cell selection

TGF-β Signaling and Vascular Morphogenesis

Mechanisms and regulation of endothelial VEGF receptor signalling

Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy with Its Homologue TIE2

Regulators of angiogenesis and strategies for their therapeutic manipulation

Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology

Controlling Angiogenesis by Two Unique TGF-β Type I Receptor Signaling Pathways.

Notch Signaling in Vascular Smooth Muscle Regulates Angiogenesis

Novel VEGF Family Members: VEGF-B, VEGF-C and VEGF-D.

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy.

Vascular-specific growth factors and blood vessel formation

The endothelial tip-stalk cell selection and shuffling during angiogenesis

Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro

Signaling by Members of the TGF-β Family in Vascular Morphogenesis and Disease

Integrated Effects of Matrix Mechanics and Vascular Endothelial Growth Factor (VEGF) on Capillary Sprouting

VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression